Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

NCT04547777 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Glioma, Malignant

Interventions

DRUG: D2C7-IT
DRUG: 2141-V11

Sponsor

Darell Bigner

Collaborators

[object Object]